Resultados de la búsqueda 131-140 of 7361 for immunosuppressant drugs

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work in ...

2. Salud de los consumidores - Mayo Clinic

   abril 2024. DEA Drug Take Back Day at Mayo Clinic in Florida April 23, 2024, 02:30 p.m. CDT · Mayo Clinic Minute: Creating an advance directive for your future ...

3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The median survival of patients with LM with treatment is generally less than 5 months. There are four FDA-approved drugs for intra-CSF use in LM, but all have ...

4. Neurología - Ensayos clínicos - Mayo Clinic

   Selumetinib is a drug that works by blocking some enzymes that low grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs ...

5. Radiología - Ensayos clínicos - Mayo Clinic

   Radioactive drugs, such as lutetium Lu 177 dotatate, may carry radiation directly to tumor cells and may reduce harm to normal cells. Lutetium Lu 177 ...

6. Medicina cardiovascular - Ensayos clínicos - Mayo Clinic

   The purpose of this study is to prospectively determine if magnetic resonance imaging (MRI) in patients with cardiac implantable electronic devices (CIED) ...

7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The median survival of patients with LM with treatment is generally less than 5 months. There are four FDA-approved drugs for intra-CSF use in LM, but all have ...

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   The standard treatment for locally advanced rectal cancer involves chemotherapy and radiation, known as 5FUCMT, (the chemotherapy drugs 5-fluorouracil/ ...

9. Neurología - Ensayos clínicos - Mayo Clinic

   Selumetinib is a drug that works by blocking some enzymes that low grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs ...

10. Neurología - Ensayos clínicos - Mayo Clinic

    Selumetinib is a drug that works by blocking some enzymes that low grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs ...